Cannabist Finalizes Delaware Asset Sale Amid Restructuring

Cannabist Company Holdings ( (TSE:CBST) ) just unveiled an update.

On May 7, 2026, Cannabist Company Holdings and its subsidiary Columbia Care Delaware completed the previously announced sale of substantially all Delaware business assets to Arboretum DE PermitCo for $16.5 million, including $14.025 million paid at closing and $2.475 million held in escrow subject to working capital and other post-closing adjustments. The divestiture comes as the company pursues court-supervised restructuring under Canada’s CCAA and related Chapter 15 proceedings in the U.S., and its audit committee has concluded that, following the Delaware closing and the Canadian court’s April 2, 2026 order, Cannabist will cease filing its Form 10-K for 2025 and future Form 10-Qs due to the cost and burden of complying with U.S. securities reporting requirements.

Spark’s Take on CBST Stock

According to Spark, TipRanks’ AI Analyst, CBST is a Underperform.

Cannabist Company Holdings is facing severe financial difficulties, with declining revenues, high leverage, and negative equity. The technical analysis indicates an overbought condition without clear momentum, and the valuation reflects unprofitability. These factors contribute to a low overall stock score.

To see Spark’s full report on CBST stock, click here.

More about Cannabist Company Holdings

The Cannabist Company Holdings Inc. operates in the cannabis industry, providing cultivation, processing and retail distribution of cannabis products through subsidiaries such as Columbia Care Delaware, LLC. The company has historically focused on regulated U.S. state markets, including Delaware, where it operated licensed cannabis assets that have now been divested as part of a broader restructuring process.

Technical Sentiment Signal: Sell

Current Market Cap: C$227.8M

See more data about CBST stock on TipRanks’ Stock Analysis page.